Evidence Brief October 2, 2026
This week’s Evidence Brief examines how the structure of a decision problem shapes the evidence it can produce. New work in CLL patient preferences, target-trial emulation, and Medicare oncology pricing shows why attribute definition, causal design, and lifecycle value strategy need to be specified before the analysis begins
Evidence Brief September 25, 2026
This week’s Evidence Brief examines what happens when evidence generation changes the decision environment itself. New studies show how genomic information can alter treatment preferences, electronic PROs can become part of the intervention, and real-world evidence quality depends on decisions made long before statistical analysis begins.
Perspective: Where a Biomarker Is Located May Matter as Much as How Much Is Present
A study of immune biomarkers in ampullary adenocarcinoma illustrates a broader evidence-generation problem: summary measures can be entirely correct and still obscure the structure that carries the signal. The question is not whether evidence should be simplified, but what may be lost when it is.
Evidence Brief September 18, 2026
This week’s Evidence Brief examines why agreement on what matters does not necessarily mean agreement on how much it matters. New oncology preference studies highlight important differences between patient, caregiver, clinician, and public perspectives, while new economic evidence shows how expanding the analysis from an isolated technology to the broader care pathway can materially change the value proposition.
Evidence Brief September 11, 2026
New work on response shift, shared decision-making, threshold pricing, and Medicare value assessment underscores a common theme: clinical outcomes, patient preferences, and economic value are all shaped by the context in which they are measured and used.
Evidence Brief September 4, 2026
From cancer-care delivery models to side-effect framing and treatment-timing definitions, this week’s evidence highlights how study design choices made upstream of analysis can materially influence quantitative results and their interpretation.
Evidence Brief August 28, 2026
How survival extrapolation, DCE design, decision burden, and changing clinical context can shape the evidence we observe. This week’s brief looks at why measured choices are not always the same thing as underlying preferences.
Start with a focused discussion
Tell us about the decision, evidence gap, or research problem you are facing. Initial consultations are used to clarify the problem, determine fit, and identify the most useful next step.